Connect your AI

HTFL HTFL Available for sale investments

Available for sale investments at other companies

Edwards LifesciencesEW

——

Other financials

Income statement

Revenue$52.6M+41.3%

Gross profit$42.2M+50.9%

Operating income-$29.5M-68.6%

Net income-$27.4M+15.4%

EPS (diluted)-$0.32+93.9%

Balance sheet

Cash & equivalents$24.4M-78.7%

Total debt$26.3M—

Total equity$285.7M+132%

Total assets$344.0M—

Cash flow

Operating cash flow-$30.1M-129%

CapEx$1.9M+71.6%

Free cash flow-$32.0M-124%

Valuation

Market cap$2.97B—

Enterprise value$2.98B—

P/S15.5×—

Profitability

Gross margin78.1%+2.4pp

Operating margin-39.7%-4.8pp

Net margin-58.4%-12.1pp

FCF margin-40.1%-2.4pp

Returns & leverage

Return on equity37.1%—

Debt / equity0.1×—

Current ratio5.6×—

Where this comes from

Reported directly by HTFL in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecurities.

The official record: HTFL’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about HTFL's available for sale investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is HTFL's available for sale investments?: HTFL (HTFL) reported available for sale investments of $241.28M in Q1 2026.